Navigation Links
SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector
Date:10/6/2009

ars.

About Ankylosing Spondylitis

Ankylosing spondylitis is a painful and progressive form of spinal arthritis, and symptoms of inflammatory back pain often first present in people under the age of 35 years. On the European continent, it is estimated that prevalence ranges from 0.2 to one percent of the entire population. It typically begins in the late teens and early 20s, and in severe cases can result in fusing of the spinal vertebrae and cause structural damage to hips and other joints. Often misdiagnosed as "just back pain" or undifferentiated arthritis, AS is a systemic inflammatory disease that, in addition to its effect on the spine, can affect internal organs, peripheral joints and vision.

About SIMPONI

SIMPONI is a human monoclonal antibody that targets and neutralizes excess TNF alpha, a protein that when overproduced in the body due to chronic inflammatory diseases can cause inflammation and damage to bones, cartilage and tissue. SIMPONI is the first once monthly subcutaneous therapy approved in the U.S., European Union and Canada for the treatment of three rheumatic conditions: rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. The approved dose for SIMPONI in the U.S., European Union and Canada is a 50 mg subcutaneous injection given once a month either through the SIMPONI SmartJect(TM) auto injector or a prefilled syringe.

Important Safety Information

In the European Union, SIMPONI is contraindicated in patients with active tuberculosis, severe infections such as sepsis, opportunistic infections, in patients with moderate or severe heart failure (NYHA Class III/IV), as well as in patients who are hypersensitive to SIMPONI or any of its excipients. Serious infections, including sepsis, pneumonia, tuberculosis, invasive fungal and other opportunistic infections have been observed with the use of TNF antagonists including SIMPONI. Some of the
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
2. New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients
3. Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
4. GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM)
5. Sequella Receives American Recovery and Reinvestment Funding Through the NIH
6. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
7. Cortheras Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure
8. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
9. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
10. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
11. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... and HOUSTON , May 28, 2015 ... EPI) today reported financial results for the second quarter and ... specified otherwise, are expressed in Canadian dollars and in accordance ... Results ESSA recorded a net loss of ... ended March 31, 2015 (Q2-2015), compared to a net loss ...
(Date:5/28/2015)... , May 28, 2015 Henry ... largest provider of health care products and services ... today reminded its customers that the Henry Schein ... and veterinarians who experience operational, logistical or financial ... in the South Central region of the U.S. ...
(Date:5/28/2015)... LONDON , May 28, 2015 This report ... and Thousand Units by the following Segments: Standard Intraocular Lenses, ... for the US, Canada , ... Asia-Pacific , Latin America , and ... the period 2013 through 2020. Also, a seven-year historic analysis ...
Breaking Medicine Technology:Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3World Intraocular Lenses Industry 2World Intraocular Lenses Industry 3World Intraocular Lenses Industry 4World Intraocular Lenses Industry 5World Intraocular Lenses Industry 6World Intraocular Lenses Industry 7World Intraocular Lenses Industry 8World Intraocular Lenses Industry 9World Intraocular Lenses Industry 10World Intraocular Lenses Industry 11World Intraocular Lenses Industry 12World Intraocular Lenses Industry 13World Intraocular Lenses Industry 14World Intraocular Lenses Industry 15World Intraocular Lenses Industry 16World Intraocular Lenses Industry 17World Intraocular Lenses Industry 18World Intraocular Lenses Industry 19World Intraocular Lenses Industry 20World Intraocular Lenses Industry 21World Intraocular Lenses Industry 22World Intraocular Lenses Industry 23World Intraocular Lenses Industry 24World Intraocular Lenses Industry 25World Intraocular Lenses Industry 26
... BioWa, Inc. announced today that it has entered into ... Tokyo based Astellas Pharma Inc., providing Agensys with access ... purpose of identifying antibodies with enhanced antibody-dependent cellular cytotoxicity ... our Agreement with Agensys, a leading monoclonal antibody organization ...
... TORONTO and BASEL, Switzerland, Nov. 15, 2010 ... co-operation created to provide clients with geographically diversified, ... production of active pharmaceutical ingredients. In ... capital efficiency, pharmaceutical development companies have been seeking ...
Cached Medicine Technology:BioWa Announces License of POTELLIGENT® Technology to Agensys 2Dalton and Lonza Announce Co-operation to Provide Contract Chemistry Services and Manufacturing 2Dalton and Lonza Announce Co-operation to Provide Contract Chemistry Services and Manufacturing 3
(Date:5/29/2015)... New England Peptide, Inc. (NEP), in ... Analysis Consortium (CPTAC) and others, today announced the ... of peptide stable isotope standards for biomarker discovery. ... tryptic peptides, offers thousands of fragments spanning over ... accessible to the biomedical research community. Each ...
(Date:5/29/2015)... 2015 On May 28th, TheCelebrityDresses.com released ... dresses and party dresses. Most of the styles in ... release includes more than 80 styles of sexy cocktail ... most popular design elements coming with the new release ... one shoulder design. Many of the new styles are ...
(Date:5/28/2015)... On Monday, June 1, KORT, The Best in ... in Shelbyville, Kentucky . Clinic Director, Chad Flickinger, PT, MPT, ... patients , “ Shelbyville is a growing community and ... to better serve the residents of Shelby County. At KORT, ... as possible by providing accessible and immediate care in a ...
(Date:5/28/2015)... 28, 2015 External Counterpulsation (EECP/ECP) has ... over the United States. There are a growing number ... can experience symptoms of angina and these patients are ... and/or bypass surgery. , “No option” patients are a ... artery disease that is considered unacceptable for heart stent ...
(Date:5/28/2015)... May 28, 2015 Today the National ... Book for the 2015 Main Residency Match®. A ... 28,906 were filled when the matching algorithm was processed. ... filled during the Match Week Supplemental Offer and Acceptance ... “We are pleased with the outcome of the 2015 ...
Breaking Medicine News(10 mins):Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3
... ... dollar Beverly Hills home, Rochelle Maize, Ally Maize and Richard Maize ventured out on a cool ... provided to the homeless and the hungry. It was a night that was going to change ... Los Angeles, CA (PRWEB) ...
... N.C., Dec. 25 Adding 30 minutes of daily physical ... a healthier 2010, says Peter Brubaker, professor of health and ... the most important step toward a healthier lifestyle, Brubaker says. ... regular physical activity even if you never lose a pound," ...
... Dec. 24 Congressman Chaka Fattah (D-PA) releases the following ... legislation: , "Senate Democrats deserve our thanks and congratulations ... do, but I am confident that the House and the ... new year we will be sending President Obama a final ...
... Today, The U.S. Conference of Mayors (USCM) congratulates the U.S. ... for millions of the uninsured. In a historic Christmas Eve ... Patient Protection and Affordable Care Act. , "Not since 1963, ... Eve. It is appropriate the most important piece of ...
... help adult cells generate embryonic-like cells, study finds , THURSDAY, ... to help fight the common cold and heal wounds, but ... adult cells generate embryonic-like stem cells, new research suggests. ... Cell Stem Cell , add to previous research that ...
... , WASHINGTON, Dec. 24 "The Senate,s historic vote ... creation of a transformational national long-term services and supports insurance ... people with disabilities. The Senate bill also includes means by ... acute and long-term problems. It will stimulate innovation in ...
Cached Medicine News:Health News:Richard Maize Inspires Wealthy to Aid Homeless During Hanukkah, Christmas 2Health News:Richard Maize Inspires Wealthy to Aid Homeless During Hanukkah, Christmas 3Health News:Richard Maize Inspires Wealthy to Aid Homeless During Hanukkah, Christmas 4Health News:Richard Maize Inspires Wealthy to Aid Homeless During Hanukkah, Christmas 5Health News:30 Minutes to Better Health in 2010 2
Binocular indirect ophthalmic lenses. Ultra-High resolutions viewing of posterior pole....
... Volk's super series slit ... resolution viewing of the ... fundus diagnostic capability, specifically ... of view, fundus image ...
Volk indirect lenses. General diagnosis & treatment....
... High Speed Pre and Post High Vacuum ... autoclave designed to cover a large of ... as well as private clinics and dental ... sterilization of medical and surgical materials such ...
Medicine Products: